Gregory T. Hradsky's most recent trade in Cyclacel Pharmaceuticals Inc was a trade of 4,748 Stock Option (right to buy) done . Disclosure was reported to the exchange on June 15, 2021.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Cyclacel Pharmaceuticals Inc | Gregory T. Hradsky | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2021 | 4,748 | 4,748 | - | - | Stock Option (right to buy) | |
| Cyclacel Pharmaceuticals Inc | Gregory T. Hradsky | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2021 | 2,374 | 2,374 (0%) | 0% | 0 | Common Stock |